총 99건 중 99건 출력
, 4/10 페이지
-
31
-
T1590 Isolated Peripancreatic Necrosis: Are Outcomes Different?
-
Parikh, Purvi;
Jester, Andrea L.;
Howard, Thomas J.;
Nakeeb, Attila;
Lillemoe, Keith D.;
Pitt, Henry A.;
Schmidt, C. Max;
Zyromski, Nicholas J.;
;
(Gastroenterology,
v.136,
2009,
pp.A-917-A-918)
-
32
-
Cytomegalovirus Infection and HIV-1 Disease Progression in Infants Born to HIV-1-Infected Women
-
Kovacs, Andrea;
Schluchter, Mark;
Easley, Kirk;
Demmler, Gail;
Shearer, William;
Russa, Philip La;
Pitt, Jane;
Cooper, Ellen;
Goldfarb, Johanna;
Hodes, David;
Kattan, Meyer;
McIntosh, Kenneth;
;
(The New England journal of medicine,
v.341,
1999,
pp.77-84)
-
33
-
Back Cover
-
Rossing, Peter;
Anker, Stefan D.;
Filippatos, Gerasimos;
Pitt, Bertram;
Ruilope, Luis M.;
Billings, Liana K.;
Green, Jennifer B.;
Koya, Daisuke;
Mosenzon, Ofri;
Pantalone, Kevin M.;
Ahlers, Christiane;
Lage, Andrea;
Lawatscheck, Robert;
Scalise, Andrea;
Bakris, George L.;
;
(Diabetes, obesity & metabolism,
v.25,
2023,
)
-
34
-
Building Interprofessional Simulations That Emphasize Flexibility and Teamwork in Treatment Planning
-
Glueck, Dehra A.;
Grice, Gloria R.;
Rea, Gail B.;
Perlmutter, Monica S.;
Rotter, Beth;
Hageman, Heather;
Pitt, Jamie;
Tucker, Sue;
Bunt, Gale;
Weber, Andrea;
McConachie, Angela;
;
(Journal of interprofessional education & practice,
v.1,
2015,
pp.60-61)
-
35
-
S-PACK: A Modular and Modifiable, Comprehensive Predeparture Preparation Curriculum for Global Health Experiences
-
St Clair, Nicole E.;
Butteris, Sabrina M.;
Cobb, Carmen;
Connolly, Emilia;
Groothuis, Elizabeth;
Jones, Andrea;
Lauden, Stephanie;
Miller, Kathleen;
Winter, Jameel;
Pitt, Michael B.;
is associate professor and director, Pediatric Residency Global Health Track, Department of Pediatrics, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin;
ORCID:.;
is associate professor, medical director, Division of Pediatric Hospital Medicine, vice chair of clinical affairs, and chief, Division of Global Pediatrics, Department of Pediatrics, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin.;
is assistant professor and codirector, Pediatric Residency Global Health Track, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin;
ORCID:.;
is assistant professor, Department of Pediatrics, University of Cincinnati and Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio;
ORCID:.;
is instructor and assistant program director, McGaw Global Health Clinical Scholars Program, Department of Pediatrics, Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children’s Hospita;
(Academic medicine : journal of the Association of American Medical Colleges,
v.94,
2019,
pp.1916-1921)
-
36
-
Pharmacokinetics of Didanosine and Drug Resistance Mutations in Infants Exposed to Zidovudine During Gestation or Postnatally and Treated With Didanosine or Zidovudine in the First Three Months of Life
-
Kovacs, Andrea;
Cowles, Mary Kathryn;
Britto, Paula;
Capparelli, Edmund;
Fowler, Mary Glenn;
Moye, Jack;
McIntosh, Ken;
Rathore, Mobeen H.;
Pitt, Jane;
Husson, Robert N.;
From the *Maternal, Child and Adolescent Center for Infectious Diseases and Virology, University of Southern California, Keck School of Medicine, Los Angeles, CA;
the †Department of Statistics and Actuarial Science, University of Iowa, Iowa City, IA;
the ‡Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA;
the §Pediatric Pharmacology Research Unit, University of California, San Diego, San Diego, CA;
the ∥Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD;
¶National Institute of Child Health and Human Development, Bethesda, MD;
the #Division of Infectious Diseases, Children’s Hospital, Harvard Medical School, Boston, MA;
the **University of Florida Health Science Center at Jacksonville, Jacksonville, FL;
and the ††Division of Infectious Diseases, Columbia University School of Medicine, New York, NY.;
(The Pediatric infectious disease journal,
v.24,
2005,
pp.503-509)
-
37
-
Efficacy and Safety of Finerenone in Patients with CKD and T2D by GLP-1RA Treatment
-
Rossing, Peter;
Agarwal, Rajiv;
Anker, Stefan D.;
Filippatos, Gerasimos;
Pitt, Bertram;
Ruilope, Luis M.;
Amod, Aslam;
Marre, Michel;
Joseph, Amer;
Lage, Andrea;
Scott, Charlie;
Bakris, George L.;
;
(The American heart journal,
v.242,
2021,
pp.160)
-
38
-
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial
-
Filippatos, Gerasimos;
Anker, Stefan D.;
Agarwal, Rajiv;
Ruilope, Luis M.;
Rossing, Peter;
Bakris, George L.;
Tasto, Christoph;
Joseph, Amer;
Kolkhof, Peter;
Lage, Andrea;
Pitt, Bertram;
National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Greece (G.F.).;
Department of Cardiology (Charité
Campus Virchow-Klinikum) and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité
Universitä
tsmedizin (S.D.A.).;
Richard L. Roudebush VA Medical Center and Indiana University, Indianapolis (R.A.).;
Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain (L.M.R.).;
Steno Diabetes Center Copenhagen, Gentofte, Denmark (P.R.).;
Department of Medicine, University of Chicago Medicine, IL (G.L.B.).;
Research and Development, Statistics and Data Insights (C.T.), Bayer AG, Wuppertal, Germany.;
Research and Development, Cardiology and Nephrology Clinical Development (A.J.), Bayer AG, Wuppertal, Germany.;
Preclinical Research Cardiovascular, Pharmaceuticals, Research and Dev;
(Circulation,
v.145,
2022,
pp.437-447)
-
39
-
406-P: Efficacy and Safety of Finerenone in Patients with CKD and T2D by GLP-1RA Treatment
-
ROSSING, PETER;
AGARWAL, RAJIV;
ANKER, STEFAN;
FILIPPATOS, GERASIMOS;
PITT, BERTRAM;
RUILOPE, LUIS M.;
AMOD, ASLAM;
MARRE, MICHEL;
JOSEPH, AMER;
LAGE, ANDREA Z.;
SCOTT, CHARLIE;
BAKRIS, GEORGE;
Gentofte, Denmark, Indianapolis, IN, Athens, Greece, Ann Arbor, MI, Madrid, Spain, Durban, South Africa, Paris, France, Berlin, Germany, Sã
o Paulo, Brazil, Reading, United Kingdom, Chicago, IL;
Gentofte, Denmark, Indianapolis, IN, Athens, Greece, Ann Arbor, MI, Madrid, Spain, Durban, South Africa, Paris, France, Berlin, Germany, Sã
o Paulo, Brazil, Reading, United Kingdom, Chicago, IL;
Gentofte, Denmark, Indianapolis, IN, Athens, Greece, Ann Arbor, MI, Madrid, Spain, Durban, South Africa, Paris, France, Berlin, Germany, Sã
o Paulo, Brazil, Reading, United Kingdom, Chicago, IL;
Gentofte, Denmark, Indianapolis, IN, Athens, Greece, Ann Arbor, MI, Madrid, Spain, Durban, South Africa, Paris, France, Berlin, Germany, Sã
o Paulo, Brazil, Reading, United Kingdom, Chicago, IL;
Gentofte, Denmark, Indianapolis, IN, Athens, Greece, Ann Arbor, MI, Madrid, Spain, Durban, South Africa, Paris, France, Berlin, Germany, Sã
o Paulo, Brazil, Reading, United Kingdom, Chic;
(Diabetes,
v.70,
2021,
pp.406-P)
-
40
-
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <small>FIDELITY</small> study
-
Rossing, Peter;
Anker, Stefan D.;
Filippatos, Gerasimos;
Pitt, Bertram;
Ruilope, Luis M.;
Billings, Liana K.;
Green, Jennifer B.;
Koya, Daisuke;
Mosenzon, Ofri;
Pantalone, Kevin M.;
Ahlers, Christiane;
Lage, Andrea;
Lawatscheck, Robert;
Scalise, Andrea;
Bakris, George L.;
Steno Diabetes Center Copenhagen Herlev Denmark;
Department of Cardiology (CVK) of German Heart Center Charité
;
Institute of Health Center for Regenerative Therapies (BCRT) German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité
Universitä
tsmedizin Berlin Germany;
Department of Cardiology, School of Medicine Attikon University Hospital, National and Kapodistrian University of Athens Athens Greece;
Department of Medicine, School of Medicine University of Michigan Ann Arbor Michigan USA;
Cardiorenal Translational Laboratory and Hypertension Unit Institute of Research imas12 Madrid Spain;
Department of Medicine NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine Skokie Illinois USA;
Division of Endocrinology, Duke Clinical Research Institute Duke University School of Medicine Durham North Carolina USA;
Department of Diabetology and Endocrinology Kanazawa Medical University Uchinada Japan;
Diabetes Unit, Dep;
(Diabetes, obesity & metabolism,
v.25,
2023,
pp.2989-2998)